Samtidig brug af stabile doser af konventionel behandling var tilladt, og 83% af patienterne fortsatte brugen af mindst et af disse behandlinger.
Concurrent use of stable doses of conventional therapies was permitted, and 83% of patients continued to receive at least one of these therapies.